SEARCH

SEARCH BY CITATION

References

  • 1
    Whiteman DC, Parsons PG, Green AC. p53 expression and risk factors for cutaneous melanoma: a case–control study. Int J Cancer 1998; 77: 8438.
  • 2
    Whiteman DC, Watt P, Purdie DM, Hughes MC, Hayward NK, Green AC. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95: 80612.
  • 3
    Olsen CM, Zens MS, Stukel TA, Sacerdote C, Chang YM, Armstrong BK, Bataille V, Berwick M, Elwood JM, Holly EA, Kirkpatrick C, Mack T, et al. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer 2009; 124: 93744.
  • 4
    Whiteman DC, Stickley M, Watt P, Hughes MC, Davis MB, Green AC. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 2006; 24: 31727.
  • 5
    Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Bronstein BR, Mihm MC, Jr., Speizer FE. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. J Natl Cancer Inst 1989; 81: 94852.
  • 6
    Kruger S, Garbe C, Buttner P, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 1992; 26: 9206.
  • 7
    Rieger E, Soyer HP, Garbe C, Buttner P, Kofler R, Weiss J, Stocker U, Kruger S, Roser M, Weckbecker J, Panizzon R, Bahmer F. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case–control study of the German Central Malignant-Melanoma Registry. Int J Cancer 1995; 62: 3937.
  • 8
    Chen YT, Dubrow R, Holford TR, Zheng T, Barnhill RL, Fine J, Berwick M. Malignant melanoma risk factors by anatomic site: a case–control study and polychotomous logistic regression analysis. Int J Cancer 1996; 67: 63643.
  • 9
    Cho E, Rosner BA, Colditz GA. Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev 2005; 14: 12414.
  • 10
    Bataille V, Sasieni P, Grulich A, Swerdlow A, McCarthy W, Hersey P, Newton Bishop JA, Cuzick J. Solar keratoses: a risk factor for melanoma but negative association with melanocytic naevi. Int J Cancer 1998; 78: 812.
  • 11
    Randi G, Naldi L, Gallus S, Di Landro A, La Vecchia C. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol 2006; 126: 210610.
  • 12
    Purdue MP, From L, Kahn HJ, Armstrong BK, Kricker A, Gallagher RP, McLaughlin JR, Klar NS, Marrett LD. Etiologic factors associated with p53 immunostaining in cutaneous malignant melanoma. Int J Cancer 2005; 117: 48693.
  • 13
    Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Brocker EB, LeBoit PE, Pinkel D, Bastian BC. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353: 213547.
  • 14
    Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 2003; 163: 176570.
  • 15
    Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 187890.
  • 16
    Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, et al. Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev 2007; 16: 9917.
  • 17
    Frost CA, Green AC, Williams GM. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol 1998; 139: 10339.
  • 18
    Autier P, Dore JF, Lejeune F, Koelmel KF, Geffeler O, Hille P, Cesarini JP, Lienard D, Liabeuf A, Joarlette M, Chemaly P, Hakim K. Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case–control study in Belgium, France and Germany. The EORTC Malignant Melanoma Cooperative Group. Melanoma Res 1994; 4: 7985.
  • 19
    English DR, Armstrong BK, Kricker A. Reproducibility of reported measurements of sun exposure in a case–control study. Cancer Epidemiol Biomarkers Prev 1998; 7: 85763.
  • 20
    Rosso S, Minarro R, Schraub S, Tumino R, Franceschi S, Zanetti R. Reproducibility of skin characteristic measurements and reported sun exposure history. Int J Epidemiol 2002; 31: 43946.
  • 21
    Kricker A, Vajdic CM, Armstrong BK. Reliability and validity of a telephone questionnaire for estimating lifetime personal sun exposure in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 242732.
  • 22
    Yu CL, Li Y, Freedman DM, Fears TR, Kwok R, Chodick G, Alexander B, Kimlin MG, Kricker A, Armstrong BK, Linet MS. Assessment of lifetime cumulative sun exposure using a self-administered questionnaire: reliability of two approaches. Cancer Epidemiol Biomarkers Prev 2009; 18: 46471.
  • 23
    Walter SD, King WD, Marrett LD. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case–control study in Ontario, Canada. Int J Epidemiol 1999; 28: 41827.
  • 24
    Zanetti R, Franceschi S, Rosso S, Colonna S, Bidoli E. Cutaneous melanoma and sunburns in childhood in a southern European population. Eur J Cancer 1992; 28A: 11726.
  • 25
    Chang YM, Barrett JH, Bishop DT, Armstrong BK, Bataille V, Bergman W, Berwick M, Bracci PM, Elwood JM, Ernstoff MS, Gallagher RP, Green AC, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009; 38: 81430.
  • 26
    Caini S, Gandini S, Sera F, Raimondi S, Fargnoli MC, Boniol M, Armstrong BK. Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur J Cancer 2009; 45: 305463.
  • 27
    Karagas MR, Stukel TA, Dykes J, Miglionico J, Greene MA, Carey M, Armstrong B, Elwood JM, Gallagher RP, Green A, Holly EA, Kirkpatrick CS, et al. A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use. Br J Cancer 2002; 86: 108592.
  • 28
    Karagas MR, Zens MS, Stukel TA, Swerdlow AJ, Rosso S, Osterlind A, Mack T, Kirkpatrick C, Holly EA, Green A, Gallagher R, Elwood JM, et al. Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control 2006; 17: 119.
  • 29
    Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the analysis of pooled data. Stat Med 2001; 20: 211530.
  • 30
    Beral V, Ramcharan S, Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 1977; 36: 8049.
  • 31
    Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case–control study. Br J Cancer 1996; 73: 160511.
  • 32
    Elwood JM, Whitehead SM, Davison J, Stewart M, Galt M. Malignant melanoma in England: risks associated with naevi, freckles, social class, hair colour, and sunburn. Int J Epidemiol 1990; 19: 80110.
  • 33
    Swerdlow AJ, English J, MacKie RM, O'Doherty CJ, Hunter JA, Clark J, Hole DJ. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) 1986; 292: 15559.
  • 34
    Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study. Br J Cancer 1985; 52: 9017.
  • 35
    Green A, Bain C. Hormonal factors and melanoma in women. Med J Aust 1985; 142: 4468.
  • 36
    Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 1995; 141: 92333.
  • 37
    Holman CD, Armstrong BK, Heenan PJ. Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 1984; 50: 67380.
  • 38
    Kirkpatrick CS, White E, Lee JA. Case–control study of malignant melanoma in Washington State. II. Diet, alcohol, and obesity. Am J Epidemiol 1994; 139: 86980.
  • 39
    Langholz B, Richardson J, Rappaport E, Waisman J, Cockburn M, Mack T. Skin characteristics and risk of superficial spreading and nodular melanoma (United States). Cancer Causes Control 2000; 11: 74150.
  • 40
    Osterlind A, Tucker MA, Stone BJ, Jensen OM. The Danish case–control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int J Cancer 1988; 42: 8214.
  • 41
    Smith MA, Fine JA, Barnhill RL, Berwick M. Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol 1998; 27: 7517.
  • 42
    Zanetti R, Franceschi S, Rosso S, Bidoli E, Colonna S. Cutaneous malignant melanoma in females: the role of hormonal and reproductive factors. Int J Epidemiol 1990; 19: 5226.
  • 43
    Green A, Battistutta D, Hart V, Leslie D, Weedon D. Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group. Am J Epidemiol 1996; 144: 103440.
  • 44
    Green AC. Premature ageing of the skin in a Queensland population. Med J Aust 1991; 155: 4734, 7–8.
  • 45
    Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarra G, et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet 2009; 41: 9205.
  • 46
    Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78: 27680.